compound semaglutide stopping FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Switching from compounded semaglutide to

Effect of pre-diabetes on future risk of stroke: meta-analysis

Ferroptosis is a potential novel diagnostic and therapeutic target for patients with cardiomyopathy

Emerging Therapies for Idiopathic Pulmonary Fibrosis, a Progressive Age-Related Disease

Targeting FABP1 expression in the liver could be beneficial as a medical treatment for fatty liver disease

It is linked to slower stomach emptying and stronger fullness signals

Case Report: We present the case of a pediatric patient with a family history that includes a father with osteochondromatosis, an 11-year-old sister with arthralgia currently under investigation, and a maternal aunt with lupus